The Association Between Asthma and Pancreatic Cancer: A Systematic Review
- 1Department of Surgery and the Jefferson Pancreas, Biliary and Related Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA
Abstract
Background: Pancreatic cancer is an aggressive malignancy, largely due to its vague clinical presentation and delayed diagnosis. Knowledge of the risk factors is essential to combat this disease. Increasing interest has been directed toward immune-related disorders and their effect on pancreatic cancer development. Studies have investigated the relationship between asthma and pancreatic cancer; however, findings are inconsistent, with some studies reporting a protective association, while others failed to detect any differences. In light of these inconsistent findings, we conducted a systematic review of the available literature to clarify the link between asthma and pancreatic cancer. Methods: We identified studies published from 1978 through December 2025 that investigated the association between asthma and pancreatic cancer using PubMed, Scopus, and Embase databases, searched on 2 February 2026. Eligible studies were English-language comparative studies evaluating the association between asthma and pancreatic cancer, including case–control and cohort studies. Eligible outcomes were pancreatic cancer incidence or pancreatic cancer mortality. Studies that did not assess both asthma and pancreatic cancer were excluded. Studies were classified by design, assessed for bias and quality using the Newcastle–Ottawa Scale, and presented as a narrative review. This review was reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) reporting guideline. Results: A total of 27 studies were included, comprising 14 case–control studies and 13 cohort studies. Overall, the available literature demonstrates discordant findings regarding the association between asthma and pancreatic cancer. While some studies suggest a potential inverse relationship, others report a null or even positive association. Conclusions: The current evidence on the association between asthma and pancreatic cancer remains inconsistent. The discrepancies across studies likely reflect variations in study design, differences in asthma ascertainment, and inconsistent adjustment for established confounders. Future studies with objective asthma diagnosis and adequate confounder control are warranted to clarify this association.
Related
- Efficacy and toxicities of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel as first-line chemotherapy for unresectable pancreatic cancer: a systematic review and meta-analysis
- Negotiating Mortality: A Qualitative Systematic Review and Thematic Synthesis of the Psychosocial Experiences of Pancreatic Cancer Across the Illness Trajectory.
- The Association Between CD40 rs1883832 Polymorphism and Cancer Susceptibility: A Systematic Review and Meta‐Analysis
- Cost-effectiveness of anti-inflammatory reliever (AIR) or maintenance and reliever therapy (MART) for mild to moderate asthma: a systematic review.
- A Systematic Review and Dose-Response Meta-Analysis of the Association Between the Age of First Pregnancy and Breast Cancer Risk
BibTeX
@article{darawsha2026association,
title = {{The Association Between Asthma and Pancreatic Cancer: A Systematic Review}},
author = {Basel Darawsha and Harish Lavu and Charles J. Yeo and Nader Hanna and Avinoam Nevler},
journal = {Cancers},
year = {2026},
month = oct,
doi = {10.3390/cancers18213457},
url = {https://www.mdpi.com/2072-6694/18/21/3457},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The Association Between Asthma and Pancreatic Cancer: A Systematic Review
AU - Basel Darawsha
AU - Harish Lavu
AU - Charles J. Yeo
AU - Nader Hanna
AU - Avinoam Nevler
PY - 2026
DA - 2026/10/26
JO - Cancers
DO - 10.3390/cancers18213457
UR - https://www.mdpi.com/2072-6694/18/21/3457
AB - Background: Pancreatic cancer is an aggressive malignancy, largely due to its vague clinical presentation and delayed diagnosis. Knowledge of the risk factors is essential to combat this disease. Increasing interest has been directed toward immune-related disorders and their effect on pancreatic cancer development. Studies have investigated the relationship between asthma and pancreatic cancer; however, findings are inconsistent, with some studies reporting a protective association, while others failed to detect any differences. In light of these inconsistent findings, we conducted a systematic review of the available literature to clarify the link between asthma and pancreatic cancer. Methods: We identified studies published from 1978 through December 2025 that investigated the association between asthma and pancreatic cancer using PubMed, Scopus, and Embase databases, searched on 2 February 2026. Eligible studies were English-language comparative studies evaluating the association between asthma and pancreatic cancer, including case–control and cohort studies. Eligible outcomes were pancreatic cancer incidence or pancreatic cancer mortality. Studies that did not assess both asthma and pancreatic cancer were excluded. Studies were classified by design, assessed for bias and quality using the Newcastle–Ottawa Scale, and presented as a narrative review. This review was reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) reporting guideline. Results: A total of 27 studies were included, comprising 14 case–control studies and 13 cohort studies. Overall, the available literature demonstrates discordant findings regarding the association between asthma and pancreatic cancer. While some studies suggest a potential inverse relationship, others report a null or even positive association. Conclusions: The current evidence on the association between asthma and pancreatic cancer remains inconsistent. The discrepancies across studies likely reflect variations in study design, differences in asthma ascertainment, and inconsistent adjustment for established confounders. Future studies with objective asthma diagnosis and adequate confounder control are warranted to clarify this association.
SN - 2072-6694
ER -